MedPath
NMPA Approval

Dasatinib Tablets

国药准字H20203743

December 29, 2020

Drug Information

达沙替尼片

片剂

20mg

化学药品

December 29, 2020

Company Information

Applicant Company

石家庄经济技术开发区扬子路88号

Manufacturing Company

石家庄经济技术开发区扬子路88号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达沙替尼片 - NMPA 批准文号 | MedPath